VIRAL HEPATITIS
Clinical trials for VIRAL HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new VIRAL HEPATITIS trials appear
Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hepatitis d: combo therapy targets stubborn infections
Disease control Recruiting nowThis study tests whether a combination of two experimental drugs, tobevibart and elebsiran, can clear or lower hepatitis D virus in adults who still have detectable virus despite taking bulevirtide. About 150 participants will receive the combo and be monitored for safety and vir…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hepatitis b drug faces off against standard treatment in kidney safety showdown
Disease control Recruiting nowThis study compares two antiviral medications, tenofovir alafenamide (TAF) and entecavir (ETV), in 140 adults with chronic hepatitis B. The goal is to see which drug better suppresses the virus and is safer for the kidneys. Participants will take one of the two drugs and be monit…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated May 20, 2026 11:53 UTC